
Uplizd's secure multi-agent AI platform moves high-concentration (>=250mg/mL) biologics from sequence to a defensible formulation strategy, compressing early CMC from a minimum 10mo to 2mo and saving $5M loss per...

Uplizd's secure multi-agent AI platform moves high-concentration (>=250mg/mL) biologics from sequence to a defensible formulation strategy, compressing early CMC from a minimum 10mo to 2mo and saving $5M loss per program. It triages sequence-level liabilities, models viscosity and self-association risk, designs excipient systems, and interprets stability. Open-weight models run inside your network perimeter, so proprietary sequences never leave.
An integrated platform of AI agents for the entire biologic formulation workflow, from sequence-level liability triage to stability interpretation.
Runs entirely inside your own network with no sequence data sent to any third-party model API, ensuring data privacy and security.
Predicts viscosity and self-association risk to guide the selection of optimal excipients and formulation conditions.
Automates the design of excipient compositions to enhance stability, solubility, and other critical quality attributes.
Reach thousands of potential users by listing your SaaS on FindYourSaaS.
Get Started Free